These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1730084)

  • 1. A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage.
    Pittman DD; Millenson M; Marquette K; Bauer K; Kaufman RJ
    Blood; 1992 Jan; 79(2):389-97. PubMed ID: 1730084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit.
    Fay PJ; Haidaris PJ; Smudzin TM
    J Biol Chem; 1991 May; 266(14):8957-62. PubMed ID: 1902833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C-catalyzed inactivation of human factor VIII and factor VIIIa. Identification of cleavage sites and correlation of proteolysis with cofactor activity.
    Fay PJ; Smudzin TM; Walker FJ
    J Biol Chem; 1991 Oct; 266(30):20139-45. PubMed ID: 1939075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo.
    Pipe SW; Eickhorst AN; McKinley SH; Saenko EL; Kaufman RJ
    Blood; 1999 Jan; 93(1):176-83. PubMed ID: 9864159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog.
    Lollar P; Parker ET
    J Biol Chem; 1991 Jul; 266(19):12481-6. PubMed ID: 1905722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity.
    Regan LM; Fay PJ
    J Biol Chem; 1995 Apr; 270(15):8546-52. PubMed ID: 7721754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
    Marquette KA; Pittman DD; Kaufman RJ
    Blood; 1995 Oct; 86(8):3026-34. PubMed ID: 7579396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosite-interactive regions in the A1 and A2 domains of factor VIII facilitate thrombin-catalyzed cleavage of heavy chain.
    Nogami K; Zhou Q; Myles T; Leung LL; Wakabayashi H; Fay PJ
    J Biol Chem; 2005 May; 280(18):18476-87. PubMed ID: 15746105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid residues 721-729 are required for full factor VIII activity.
    Kjalke M; Heding A; Talbo G; Persson E; Thomsen J; Ezban M
    Eur J Biochem; 1995 Dec; 234(3):773-9. PubMed ID: 8575434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the B domain for factor VIII and factor V expression and function.
    Pittman DD; Marquette KA; Kaufman RJ
    Blood; 1994 Dec; 84(12):4214-25. PubMed ID: 7994036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity.
    Takeyama M; Nogami K; Matsumoto T; Soeda T; Suzuki T; Hattori K; Shima M
    Thromb Haemost; 2010 Jan; 103(1):94-102. PubMed ID: 20062922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII.
    Pittman DD; Wang JH; Kaufman RJ
    Biochemistry; 1992 Apr; 31(13):3315-25. PubMed ID: 1554716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII delta II.
    Krishnan S; Kolbe HV; Lepage P; Faure T; Sauerwald R; de la Salle H; Muller C; Bihoreau N; Paolantonacci P; Roitsch C
    Eur J Biochem; 1991 Feb; 195(3):637-44. PubMed ID: 1900236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII C2 domain contains the thrombin-binding site responsible for thrombin-catalyzed cleavage at Arg1689.
    Nogami K; Shima M; Hosokawa K; Nagata M; Koide T; Saenko EL; Tanaka I; Shibata M; Yoshioka A
    J Biol Chem; 2000 Aug; 275(33):25774-80. PubMed ID: 10831589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa.
    Wakabayashi H; Fay PJ
    J Biol Chem; 2008 Apr; 283(17):11645-51. PubMed ID: 18299331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa.
    Fay PJ; Smudzin TM
    J Biol Chem; 1992 Jul; 267(19):13246-50. PubMed ID: 1618828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.
    Wakabayashi H; Monaghan M; Fay PJ
    J Biol Chem; 2014 May; 289(20):14020-9. PubMed ID: 24692542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemophilia A mutations within the factor VIII A2-A3 subunit interface destabilize factor VIIIa and cause one-stage/two-stage activity discrepancy.
    Hakeos WH; Miao H; Sirachainan N; Kemball-Cook G; Saenko EL; Kaufman RJ; Pipe SW
    Thromb Haemost; 2002 Nov; 88(5):781-7. PubMed ID: 12428094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
    Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
    J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.
    Donath MJ; Lenting PJ; Van Mourik JA; Mertens K
    Eur J Biochem; 1996 Sep; 240(2):365-72. PubMed ID: 8841400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.